Sareum - Specialists in Structure-based Drug Discovery
Print the page Smaller text Larger text

 

Strategic Review
02 May, 2008

Notification of Shareholder Interest
24 April, 2008

Fundraising
14 April, 2008

Sareum to Present at AACR Annual Meeting
10 April, 2008

Extension of Johnson & Johnson Agreement
31 March, 2008

RSS news feed News feed
requires RSS news reader

Sareum Holdings
Last Trading 0.39
Trade Time 16:24am
Change 0.00
Open 0.39
Day's Range 0.36 - 0.41
Volume 1297949
Sareum's structure-based drug discovery expertise is building value and generating revenue by:
Providing protein structure-based research services to accelerate customers’ drug discovery programmes
Developing oncology drug candidates for licensing to pharmaceutical companies
Providing protein structure-based research services to accelerate customers’ drug discovery programmes
Developing oncology drug candidates for licensing to pharmaceutical companies
Learn more about Sareum’s capabilities in Fragment Screening, Structure-based Lead Optimisation and Protein Structure Determination
Learn more about Sareum’s pre-clinical oncology pipeline of targeted small molecule drug candidates

 

Website last updated on: 7-April-2008
 


Requires RSS news reader

Requires MS Word

Requires Adobe Acrobat Reader


site map

email: info@sareum.co.uk tel: +44 (0) 1223 497700 fax: +44 (0) 1223 497701